Pliant Therapeutics, Inc. Share Price
PLRXPliant Therapeutics, Inc. Stock Performance
Open $1.69 | Prev. Close $1.79 | Circuit Range N/A |
Day Range $1.67 - $1.81 | Year Range $1.10 - $15.80 | Volume 21,083 |
Average Traded $1.76 |
Pliant Therapeutics, Inc. Share Price Chart
About Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Pliant Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.69 | $1.77 | +0.00% |
12-Nov-25 | $1.69 | $1.77 | +5.36% |
11-Nov-25 | $1.61 | $1.68 | +3.70% |
10-Nov-25 | $1.57 | $1.62 | +2.53% |
07-Nov-25 | $1.52 | $1.58 | +3.95% |
06-Nov-25 | $1.63 | $1.52 | -7.60% |
05-Nov-25 | $1.58 | $1.65 | +2.49% |
FAQs on Pliant Therapeutics, Inc. Share Price
Can I buy Pliant Therapeutics, Inc. shares in India?
What is the share price of Pliant Therapeutics, Inc.?
What is the 5 year returns of Pliant Therapeutics, Inc.?
What are the high & low stock price of Pliant Therapeutics, Inc. today?
What is the 52-week high and low of Pliant Therapeutics, Inc. stock?